rcad26.mos1.hiv-env
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2015 (NCT02366013)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- rcad26.mos1.hiv-env
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02366013 | Phase 1 | Jan 1, 2015 | Harvard University, International AIDS Vaccine Initiative, University of Rochester |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Harvard University | Academic/Hospital | 1 | 0 | 1 | 2015 |
| International AIDS Vaccine Initiative | Academic/Hospital | 1 | 1 | 1 | 2015 |
| University of Rochester | Academic/Hospital | 1 | 0 | 1 | 2015 |
3 organizations
Page 1 / 1